Free Trial

Icon (ICLR) Competitors

Icon logo
$180.01 +2.17 (+1.22%)
Closing price 04:00 PM Eastern
Extended Trading
$180.02 +0.00 (+0.00%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICLR vs. MEDP, CRL, IQV, TMO, WCN, TCOM, RDDT, CPAY, TOST, and AER

Should you be buying Icon stock or one of its competitors? The main competitors of Icon include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Thermo Fisher Scientific (TMO), Waste Connections (WCN), Trip.com Group (TCOM), Reddit (RDDT), Corpay (CPAY), Toast (TOST), and Aercap (AER).

Icon vs. Its Competitors

Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Medpace has a net margin of 18.74% compared to Icon's net margin of 9.82%. Medpace's return on equity of 67.66% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace18.74% 67.66% 21.86%
Icon 9.82%10.95%6.23%

Medpace has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Medpace currently has a consensus target price of $412.73, suggesting a potential downside of 14.23%. Icon has a consensus target price of $219.64, suggesting a potential upside of 22.02%. Given Icon's stronger consensus rating and higher possible upside, analysts clearly believe Icon is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93
Icon
0 Sell rating(s)
6 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.76

Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.23B6.06$404.39M$13.4535.78
Icon$8.28B1.76$791.47M$9.7218.52

In the previous week, Medpace had 21 more articles in the media than Icon. MarketBeat recorded 28 mentions for Medpace and 7 mentions for Icon. Medpace's average media sentiment score of 1.46 beat Icon's score of 1.03 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
21 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Icon
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Medpace beats Icon on 9 of the 17 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICLR vs. The Competition

MetricIconMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$14.54B$7.67B$5.75B$9.83B
Dividend YieldN/A2.66%6.66%4.49%
P/E Ratio18.5278.6782.4426.63
Price / Sales1.7646.62530.43110.53
Price / Cash8.8824.8225.7028.92
Price / Book1.5219.5910.646.56
Net Income$791.47M$242.04M$3.28B$266.04M
7 Day Performance3.45%-0.73%-0.08%-0.58%
1 Month Performance8.15%4.61%10.36%6.24%
1 Year Performance-42.35%9.15%49.00%22.21%

Icon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICLR
Icon
3.7818 of 5 stars
$180.01
+1.2%
$219.64
+22.0%
-44.8%$14.54B$8.28B18.5241,900News Coverage
Positive News
Analyst Forecast
Gap Up
MEDP
Medpace
4.5366 of 5 stars
$466.80
+0.7%
$406.60
-12.9%
+33.2%$13.03B$2.11B34.715,900Positive News
Analyst Downgrade
CRL
Charles River Laboratories International
3.5377 of 5 stars
$164.03
+1.4%
$175.69
+7.1%
-18.4%$7.96B$4.05B-123.3320,100Short Interest ↑
Analyst Revision
IQV
IQVIA
4.8939 of 5 stars
$188.08
-1.6%
$228.62
+21.6%
-26.9%$32.50B$15.41B27.2288,000Positive News
Analyst Forecast
TMO
Thermo Fisher Scientific
4.9235 of 5 stars
$490.73
-1.9%
$593.00
+20.8%
-20.9%$188.80B$42.88B28.38125,000Positive News
Analyst Forecast
Insider Trade
WCN
Waste Connections
4.8297 of 5 stars
$182.36
-1.3%
$215.00
+17.9%
-2.0%$47.75B$9.23B73.5323,854Positive News
TCOM
Trip.com Group
3.8593 of 5 stars
$65.93
+1.6%
$77.25
+17.2%
+51.9%$42.41B$7.30B19.1141,073
RDDT
Reddit
3.2446 of 5 stars
$219.96
+1.2%
$175.38
-20.3%
+266.6%$40.67B$1.30B199.962,233Positive News
Gap Up
CPAY
Corpay
4.1671 of 5 stars
$322.67
-2.6%
$399.43
+23.8%
+0.7%$23.39B$3.97B21.9211,200Positive News
TOST
Toast
3.8391 of 5 stars
$43.42
-1.3%
$45.54
+4.9%
+76.3%$22.44B$4.96B127.715,700Positive News
Short Interest ↓
AER
Aercap
2.9698 of 5 stars
$120.48
+0.9%
$122.57
+1.7%
+27.9%$22.31B$8.00B7.49740News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ICLR) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners